Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-017307

President sold 15,000 shares at an average $58.32 ($874,743)

  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-03-01 Option exercise +15,000 $6.55 $98,250 15,000 D: show line 1 in the form
RUBINSTEIN JULIE President 2021-03-01 Sale −4,684 $57.54 $269,517 10,316 D: show line 2 in the form
RUBINSTEIN JULIE President 2021-03-01 Sale −9,471 $58.64 $555,379 845 D: show line 3 in the form
RUBINSTEIN JULIE President 2021-03-01 Sale −845 $58.99 $49,847 0 D: show line 4 in the form
Open-market sales · 15,000 sh · avg $58.32 · $874,743

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
RUBINSTEIN JULIE President 2021-03-01 Option exercise · Stock Option (Right to Buy) −15,000 225,325 D: show line 5 in the form
Loading xslF345X03/doc4.xml…